<DOC>
	<DOCNO>NCT02524444</DOCNO>
	<brief_summary>Randomized control single blind prospective comparative study .</brief_summary>
	<brief_title>A Comparative Study Mefloquine S-P Prophylaxis Against Malaria Pregnant HIV + Patients</brief_title>
	<detailed_description>This study intend randomize control single blind prospective comparative study conduct compare efficacy three , monthly dos sulphadoxine-pyrimethamine intermittent preventive therapy Mefloquine as-intermittent preventive therapy HIV-infected pregnant woman .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<criteria>Pregnant HIV positive patient Gestational age 16 week No history use Mefloquine Sulphadoxine Pyrimethamine four week prior recruitment . Anaemia pack cell volume le 30 % Pre exist medical condition Diabetes Mellitus , Hypertension Allergy Sulphadoxine Pyrimethamine Mefloquine Nonconsenting patient Multiple gestation Known psychiatric illness Known seizure disorder History severe renal hepatic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Intermittent preventive therapy</keyword>
	<keyword>malaria</keyword>
	<keyword>pregnant</keyword>
	<keyword>HIV positive</keyword>
	<keyword>Prevention</keyword>
</DOC>